A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
24-week study to evaluate the efficacy and safety of macitentan for the treatment of portopulmonary hypertension.
Main Inclusion Criteria:
Main Exclusion Criteria:
Gainesville, Florida 32610, United States
Dallas, Texas 75390-8550, United States
Porto Alegre, 92020-090, Brazil
São Paulo, 05403-000, Brazil
Prague, 128 08, Czechia
Prague, 140 21, Czechia
Rennes, 35033, France
Dresden, 01307, Germany
Giessen, 35392, Germany
Heidelberg, 69126, Germany
Leipzig, 04103, Germany